Skip to content

Effect of music therapy on the half effective dose of remazolam causing loss of consciousness in female patients

Effect of music therapy on the half effective dose of remazolam causing loss of consciousness in female patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086458
Enrollment
Unknown
Registered
2024-07-02
Start date
2024-07-04
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological disease

Interventions

Remazolam group:Remazolam was administered intravenously after admission.The initial dose was 0.2mg/kg.To observe whether the consciousness disappeared within 1min after remazolam administration.The n
Remazolam combined with music therapy group:Patients were given music of their choice for 5 minutes and then remazolam was injected intravenously.To observe whether the consciousness disappeared withi

Sponsors

Fuyang Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who planned to undergo gynecological hysteroscopic surgery were classified as ASA grade I-II; 2. Age 18-60 years old; 3. BMI18-30kg/m²; 4. Normal communication; 5. Volunteer to be tested and sign informed consent

Exclusion criteria

Exclusion criteria: 1. Serious respiratory and circulatory diseases: such as serious coronary heart disease, COPD, etc.; 2. Endocrine system diseases: pituitary tumor, severe diabetes, increased cortisol, pheochromocytoma, etc.; 3. Mental illness: such as schizophrenia, depression, chronic analgesic drug use history, alcoholism history, opioid dependence; 4. Intellectual disability, sleep disorder, consciousness dysfunction, etc. 5. Known to be allergic to experimental drugs and other drugs.

Design outcomes

Primary

MeasureTime frame
Sequential results of loss of consciousness induced by remazolam and corresponding dose;

Secondary

MeasureTime frame
Blood pressure and heart rate;Bispectralindex (BIS);Respiratory rate;Blood Oxygen saturation;Occurrence of respiratory depression;Occurrence of nausea and vomiting; Perioperative adverse events;The Modified Observer’s Assessment of Alertness and Sedation scale;

Countries

China

Contacts

Public ContactJinpeng Zhang

Fuyang Hospital of Anhui Medical University

317435583@qq.com+86 150 5691 5175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026